Our findings revealed an increasing trend of PDR from 2019 to 2022, with resistance against NNRTIs being the most prevalent and peaking in 2022.
← all excerpts
Molecular epidemiology and pretreatment drug resistance of HIV-1 among newly diagnosed individuals in Nanning City, Guangxi, China.
1
—
—